PTGS2 and colitis: Pharmacological proprieties of geraniol were initially investigated by our research group in a mouse model of colitis, in which geraniol was able to reduce colon inflammation via inhibiting inflammatory cytokine synthesis, decreasing the intestinal COX-2 expression, and the strong amelioration of intestinal microbiota [33].